stockrowCertara, Inc.
CERT Healthcare Health Information Services
- Revenue
- −9.29%
- EPS
- +266.0%
- Free cash flow
- −12.1%
- Total debt
- −0.79%
Quarter to September 2026, against a year earlier
Follow CERT
Alert me
Certara, Inc. (CERT) EV/Sales
As of 6 November 2026, Certara, Inc. (CERT) trades at a EV/Sales of 4.8×. Over the past ten years it has ranged from 0.0× (December 2020) to 24.0× (November 2021); the current reading is higher than 25% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 3.6× | (23.55%) |
| FY2024 | 4.7× | (40.35%) |
| FY2023 | 7.9× | 2.48% |
| FY2022 | 7.7× | (49.23%) |
| FY2021 | 15.3× | (17.74%) |
| FY2020 | 18.6× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 3.7× | 35.61% |
| Jun 2026 | 2.7× | 10.31% |
| Mar 2026 | 2.5× | (31.44%) |
| Dec 2025 | 3.6× | (27.68%) |
| 23 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| PRVA Privia Health Group, Inc. compare | 1.1× |
| TDOC Teladoc Health, Inc. compare | 1.2× |
| OMCL Omnicell, Inc. compare | 1.4× |
| PHR Phreesia, Inc. compare | 1.7× |
| GDRX GoodRx Holdings, Inc. compare | 1.8× |
| HSTM HealthStream, Inc. compare | 2.4× |
| OMDA Omada Health, Inc. compare | 3.0× |
| CERT Certara, Inc. | 4.9× |
| SDGR Schrodinger, Inc. compare | 6.7× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)